Cargando…
Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
The principal hallmark of Parkinson’s disease (PD) is the selective neurodegeneration of dopaminergic neurones. Mounting evidence suggests that astrocytes may contribute to dopaminergic neurodegeneration through decreased homoeostatic support and deficient neuroprotection. In this study, we generate...
Autores principales: | Ramos-Gonzalez, Paula, Mato, Susana, Chara, Juan Carlos, Verkhratsky, Alexei, Matute, Carlos, Cavaliere, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009947/ https://www.ncbi.nlm.nih.gov/pubmed/33785762 http://dx.doi.org/10.1038/s41531-021-00175-w |
Ejemplares similares
-
Electroacupuncture prevents astrocyte atrophy to alleviate depression
por: Lin, Si-Si, et al.
Publicado: (2023) -
Pathological Role for Exocytotic Glutamate Release from Astrocytes in Hepatic Encephalopathy
por: Montana, Vedrana, et al.
Publicado: (2014) -
Pathological Functions of LRRK2 in Parkinson’s Disease
por: Jeong, Ga Ram, et al.
Publicado: (2020) -
Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease
por: Yeh, Chia-Yu, et al.
Publicado: (2011) -
The G2019S LRRK2 Mutation is Rare in Korean Patients with Parkinson's Disease and Multiple System Atrophy
por: Cho, Jin-Whan, et al.
Publicado: (2009)